Patents by Inventor Blake COCHRAN

Blake COCHRAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides for beta-cell survival and insulin production
    Patent number: 12698319
    Abstract: A method to prevent a disease, comprising: (1) administering a peptide comprising Delta6PV into a subject comprising a human or an animal; wherein the disease comprises one of more of Type 1 diabetes, rheumatoid arthritis, lupus, Sjogren's syndrome, multiple sclerosis, Graves' disease, giant cell arteritis, ankylosing spondylitis, and Guillain Barre Syndrome; and (2) monitoring the disease in the subject.
    Type: Grant
    Filed: September 9, 2025
    Date of Patent: August 4, 2026
    Assignees: University of New South Wales
    Inventors: Kerry-Anne Rye, Madhav Devalaraja, Maté Biro, Blake Cochran, Thomas King, Szun Tay, Feyza Colakoglu, Vanesaa Prajitno
  • PEPTIDES FOR BETA-CELL SURVIVAL AND INSULIN PRODUCTION
    Publication number: 20260008836
    Abstract: A method to prevent a disease, comprising: (1) administering a peptide comprising Delta6PV into a subject comprising a human or an animal; wherein the disease comprises one of more of Type 1 Diabetes, Rheumatoid arthritis, Lupus, Sjogren's syndrome, Multiple Sclerosis, Grave's disease, Giant cell artereitis, Ankylosing spondylitis, and Guillian Barre Syndrome; and (2) monitoring the disease in the subject.
    Type: Application
    Filed: September 9, 2025
    Publication date: January 8, 2026
    Inventors: Kerry-Anne RYE, Madhav DEVALARAJA, Maté BIRO, Blake COCHRAN, Thomas KING, Szun TAY, Feyza COLAKOGLU, Vanesaa PRAJITNO
  • PEPTIDES FOR BETA-CELL SURVIVAL AND INSULIN PRODUCTION
    Publication number: 20240043499
    Abstract: A method to prevent a disease, comprising: (1) administering a peptide comprising Delta6PV into a subject comprising a human or an animal; wherein the disease comprises one of more of Type 1 Diabetes, Rheumatoid arthritis, Lupus, Sjogren's syndrome, Multiple Sclerosis, Grave's disease, Giant cell artereitis, Ankylosing spondylitis, and Guillian Barre Syndrome; and (2) monitoring the disease in the subject.
    Type: Application
    Filed: August 8, 2023
    Publication date: February 8, 2024
    Inventors: Kerry-Anne RYE, Madhav DEVALARAJA, Maté BIRO, Blake COCHRAN, Thomas KING, Szun S. TAY, Feyza COLAKOGLU